BWM
BMY icon

Baystate Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Baystate Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$60.5K Sell
1,179
-125
-10% -$6.56K ﹤0.01% 350
2023
Q3 		$75.7K Sell
1,304
-13
-1% -$797 0.01% 280
2023
Q2 		$84.2K Sell
1,317
-16
-1% -$1.07K 0.01% 275
2023
Q1 		$92.5K Buy
1,333
+21
+2% +$1.48K 0.01% 266
2022
Q4 		$94K Buy
1,312
+220
+20% +$16.6K 0.01% 257
2022
Q3 		$78K Buy
1,092
+7
+0.6% +$508 0.01% 259
2022
Q2 		$84K Buy
1,085
+8
+0.7% +$609 0.01% 255
2022
Q1 		$79K Buy
1,077
+9
+0.8% +$604 0.01% 265
2021
Q4 		$67K Buy
1,068
+9
+0.8% +$528 0.01% 287
2021
Q3 		$63K Sell
1,059
-91
-8% -$5.99K 0.01% 268
2021
Q2 		$77K Buy
1,150
+516
+81% +$33.6K 0.01% 237
2021
Q1 		$40K Buy
634
+5
+0.8% +$311 ﹤0.01% 285
2020
Q4 		$39K Sell
629
-327
-34% -$20.1K ﹤0.01% 273
2020
Q3 		$58K Buy
956
+510
+114% +$30.7K 0.01% 205
2020
Q2 		$26K Buy
446
+21
+5% +$1.26K ﹤0.01% 276
2020
Q1 		$24K Buy
425
+3
+0.7% +$183 ﹤0.01% 263
2019
Q4 		$27K Buy
422
+89
+27% +$5.1K ﹤0.01% 286
2019
Q3 		$17K Buy
333
+4
+1% +$188 ﹤0.01% 303
2019
Q2 		$15K Buy
329
+15
+5% +$699 ﹤0.01% 327
2019
Q1 		$14K Buy
314
+3
+1% +$149 ﹤0.01% 341
2018
Q4 		$16K Sell
311
-498
-62% -$26.8K ﹤0.01% 325
2018
Q3 		$49K Buy
809
+330
+69% +$19.6K 0.01% 203
2018
Q2 		$27K Sell
479
-358
-43% -$19.3K ﹤0.01% 256
2018
Q1 		$43K Sell
837
-631
-43% -$40.6K 0.01% 202
2017
Q4 		$93K Buy
1,468
+1,221
+494% +$76.4K 0.01% 143
2017
Q3 		$16K Buy
247
+2
+0.8% +$117 ﹤0.01% 302
2017
Q2 		$13K Sell
245
-199
-45% -$10.8K ﹤0.01% 316
2017
Q1 		$24K Sell
444
-169
-28% -$9.27K ﹤0.01% 249
2016
Q4 		$36K Buy
+613
New +$33.5K 0.01% 172
2013
Q3 		– Sell
-1,000
Closed -$45K – 48
2013
Q2 		$45K Buy
+1,000
New +$43.4K 0.02% 107

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Baystate Wealth Management's BMY Position: Q4 2023 in Review

Baystate Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 9.6% in Q4 2023, selling an estimated $6.56K and leaving 1,179 shares worth $60.5K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Baystate Wealth Management first reported a position in BMY in Q2 2013 and has held it in 30 quarters since. The position peaked at $94K in Q4 2022. 2,365 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Baystate Wealth Management held 1,179 shares of Bristol-Myers Squibb worth $60.5K as of Q4 2023.
  • Baystate Wealth Management sold 125 Bristol-Myers Squibb shares in Q4 2023, an estimated $6.56K.
  • Bristol-Myers Squibb made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #350 holding.
  • Baystate Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 30 quarters since.
  • Baystate Wealth Management's Bristol-Myers Squibb position peaked at $94K in Q4 2022.
  • 2,365 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.